Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $358.35 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $252.36 | 2 | $0 (2021) |
| Myriad Genetic Laboratories, Inc. | $93.81 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12.18 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $346.17 | 3 | AstraZeneca Pharmaceuticals LP ($252.36) |
| 2019 | $12.18 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($12.18) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2021 | Myriad Genetic Laboratories, Inc. | myChoice CDx (Device) | Food and Beverage | Cash or cash equivalent | $93.81 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $127.36 | General |
| Category: Oncology | ||||||
| 05/06/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 07/10/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 908 | 1,550 | $553,784 | $50,728 |
| 2022 | 14 | 830 | 1,282 | $318,832 | $40,749 |
| 2021 | 11 | 811 | 1,283 | $435,515 | $44,479 |
| 2020 | 11 | 1,017 | 1,606 | $379,854 | $60,855 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 369 | 645 | $198,368 | $17,847 | 9.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 102 | 173 | $109,635 | $10,719 | 9.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 60 | 229 | $61,429 | $4,886 | 8.0% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 30 | 30 | $27,450 | $4,028 | 14.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 130 | 146 | $37,640 | $3,822 | 10.2% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 37 | 104 | $43,492 | $3,249 | 7.5% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 24 | 24 | $24,779 | $2,621 | 10.6% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Facility | 2023 | 24 | 47 | $30,720 | $1,338 | 4.4% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2023 | 18 | 26 | $7,633 | $1,216 | 15.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 34 | 39 | $7,197 | $334.21 | 4.6% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 13 | 13 | $2,275 | $271.44 | 11.9% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 19 | 25 | $1,029 | $233.79 | 22.7% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 48 | 49 | $2,138 | $163.70 | 7.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 235 | 411 | $125,601 | $11,870 | 9.5% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 80 | 159 | $68,651 | $10,103 | 14.7% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2022 | 33 | 36 | $22,400 | $4,037 | 18.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 42 | 142 | $19,496 | $3,086 | 15.8% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Facility | 2022 | 41 | 63 | $16,187 | $3,021 | 18.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 80 | 93 | $14,913 | $2,495 | 16.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 15 | 22 | $11,644 | $1,153 | 9.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 13 | 34 | $6,040 | $1,094 | 18.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2022 | 27 | 38 | $4,748 | $780.61 | 16.4% |
| 88329 | Pathology examination of specimen during surgery | Facility | 2022 | 21 | 23 | $4,087 | $625.38 | 15.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 24 | 28 | $4,900 | $599.45 | 12.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 63 | 66 | $12,340 | $581.07 | 4.7% |
About Dr. Mark Mentrikoski, M.D
Dr. Mark Mentrikoski, M.D is a Anatomic Pathology healthcare provider based in Danville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1427372044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mentrikoski, M.D has received a total of $358.35 in payments from pharmaceutical and medical device companies, with $346.17 received in 2021. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($358.35).
As a Medicare-enrolled provider, Mentrikoski has provided services to 3,566 Medicare beneficiaries, totaling 5,721 services with total Medicare billing of $196,812. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology, Anatomic Pathology & Clinical Pathology
- Location Danville, PA
- Active Since 03/25/2010
- Last Updated 10/20/2023
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1427372044
Products in Payments
- LYNPARZA (Drug) $252.36
- myChoice CDx (Device) $93.81
- XIFAXAN (Drug) $12.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Danville
Dr. Panayota Kotsali, Md, MD
Anatomic Pathology — Payments: $44.71
George Lin, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $17.36
Fouad Boctor, Md, MD
Anatomic Pathology
Frank Fromowitz, M.d, M.D
Anatomic Pathology
Farnaz Tahmasebi, Md, MD
Anatomic Pathology